01 16Boehringer Ingelheim (Canada) Ltd.
02 4Gowling Lafleur Henderson LLP
03 43Pfizer Canada Inc.
04 8Servier Canada Inc.
05 4Shire Canada Inc.
06 120Upjohn Canada ULC
01 31341196
02 42060624
03 42147056
04 82150372
05 32170278
06 82220018
07 82220455
08 82220458
09 82301732
10 42352436
11 32423825
12 82444554
13 82450111
14 82521776
15 82521792
16 82521828
17 82521833
18 82521887
19 82521891
20 82521908
21 82521933
22 82521953
23 82521956
24 82521958
25 82521980
26 82522899
27 42534006
28 42582049
29 32644467
30 32800946
01 4Aliskiren | Amlodipine Besylate
02 3Amlodipine Besylate
03 160Amlodipine besylate | Atorvastatin calcium
04 12PERINDOPRIL ARGININE | AMLODIPINE BESYLATE
05 16Telmisartan | Amlodipine Besylate
01 12TABLET
02 183Tablet
01 42012-02-04
02 82013-12-20
03 32014-08-10
04 42015-04-13
05 162016-07-08
06 82016-07-16
07 32018-03-06
08 82018-08-11
09 42020-01-07
10 1122022-05-21
11 82022-07-29
12 32023-04-03
13 42024-07-24
14 42025-10-29
15 32027-02-26
16 32033-01-03
Patent Expiration Date : 2020-01-07
Date Granted : 2010-03-23
Telmisartan, Amlodipine Besylate
Brand Name : TWYNSTA
Patent Number : 2352436
Filing Date : 2000-01-07
Strength per Unit : 40 / 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-01-07
Date Granted : 2010-03-23
Patent Expiration Date : 2024-07-24
Date Granted : 2010-07-13
Telmisartan, Amlodipine Besylate
Brand Name : TWYNSTA
Patent Number : 2534006
Filing Date : 2004-07-24
Strength per Unit : 40 / 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-07-24
Date Granted : 2010-07-13
Patent Expiration Date : 2025-10-29
Date Granted : 2010-08-24
Telmisartan, Amlodipine Besylate
Brand Name : TWYNSTA
Patent Number : 2582049
Filing Date : 2005-10-29
Strength per Unit : 40 / 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-10-29
Date Granted : 2010-08-24
Patent Expiration Date : 2012-02-04
Date Granted : 1999-12-21
Telmisartan, Amlodipine Besylate
Brand Name : TWYNSTA
Patent Number : 2060624
Filing Date : 1992-02-04
Strength per Unit : 40 / 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-02-04
Date Granted : 1999-12-21
Patent Expiration Date : 2020-01-07
Date Granted : 2010-03-23
Telmisartan, Amlodipine Besylate
Brand Name : TWYNSTA
Patent Number : 2352436
Filing Date : 2000-01-07
Strength per Unit : 40 / 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-01-07
Date Granted : 2010-03-23
Patent Expiration Date : 2024-07-24
Date Granted : 2010-07-13
Telmisartan, Amlodipine Besylate
Brand Name : TWYNSTA
Patent Number : 2534006
Filing Date : 2004-07-24
Strength per Unit : 40 / 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-07-24
Date Granted : 2010-07-13
Patent Expiration Date : 2025-10-29
Date Granted : 2010-08-24
Telmisartan, Amlodipine Besylate
Brand Name : TWYNSTA
Patent Number : 2582049
Filing Date : 2005-10-29
Strength per Unit : 40 / 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-10-29
Date Granted : 2010-08-24
Patent Expiration Date : 2012-02-04
Date Granted : 1999-12-21
Telmisartan, Amlodipine Besylate
Brand Name : TWYNSTA
Patent Number : 2060624
Filing Date : 1992-02-04
Strength per Unit : 40 / 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-02-04
Date Granted : 1999-12-21
Patent Expiration Date : 2020-01-07
Date Granted : 2010-03-23
Telmisartan, Amlodipine Besylate
Brand Name : TWYNSTA
Patent Number : 2352436
Filing Date : 2000-01-07
Strength per Unit : 80 / 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-01-07
Date Granted : 2010-03-23
Patent Expiration Date : 2024-07-24
Date Granted : 2010-07-13
Telmisartan, Amlodipine Besylate
Brand Name : TWYNSTA
Patent Number : 2534006
Filing Date : 2004-07-24
Strength per Unit : 80 / 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-07-24
Date Granted : 2010-07-13
